Time | Title | Chair/Speaker |
---|---|---|
08:55-09:00 | Registration | |
09:00-09:01 | Moderator |
Hye Ryoun Jang Chair of Scientific Committee of CGTI, Samsung Medical Center, Sungkyunkwan University School of Medicine |
09:01-09:04 | Opening Remarks |
Yun Sil Chang Director of Cell and Gene Therapy Institute(CGTI), Samsung Medical Center(SMC), Director of Samsung Advanced Institute for Health Sciences and Technology(SAIHST), Sungkyunkwan University |
09:04-09:07 | Welcome Address |
WooSeong Huh Executive Vice President, Chief Research Officer, Samsung Medical Center |
09:07-09:10 | Congratulatory Address |
Seung Woo Park President & CEO of Samsung Medical Center |
09:10-09:15 | Congratulatory Address |
Eunyoung Jung Director General of Bureau of Health Industry, Ministry of Health and Welfare |
09:15-09:30 | Startup G-CROWN Platform |
Jeehun Lee Samsung Medical Center, Sungkyunkwan University School of Medicine |
09:30-09:35 | Discussion | |
Session I. Translational & Clinical Research of Cell · Gene therapy for Incurable Diseases | ||
Chair : Yun Sil Chang (Director of CGTI, SMC, Director of SAIHST, Sungkyunkwan University) Dongho Choi (Hanyang University College of Medicine) |
||
09:35-10:00 | OC15-Current State of the Art of Cellbased Therapy for Aging Frailty and Neuro-Cognitive Disorders |
Joshua M Hare University of Miami, USA |
10:00-10:05 | Discussion | |
10:05-10:30 | Cardiovascular Regeneration with iPSCs and Reprogramming |
Young-Sup Yoon Yonsei University / Emory University, USA |
10:30-10:35 | Discussion | |
10:35-10:45 | Break | |
Session II. Perspective: Advanced Technology of Cell · Gene therapy to Clinical | ||
Chair : Ji Hyeon Ju (Seoul St. Mary's Hospital, The Catholic University of Korea) Sang Jin Kim (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
10:45-11:00 | Transplantation of cultivated limbal stem cell sheet in corneal blindness |
So-Hyang Chung College of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital |
11:00-11:15 | High-Purity Functional Corneal Endothelial Cells from Human Induced Pluripotent Stem Cells |
Hun Lee Asan Medical Center, University of Ulsan College of Medicine |
11:15-11:25 | Discussion | |
11:25-12:30 | Lunch | |
Session III. Recent Advances and Future Perspectives I | ||
Chair : Jae Ho Kim (Pusan National University School of Medicine) Hye Ryoun Jang (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
12:30-12:45 | Advances in Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia: Translational and Clinical Insights |
So Yoon Ahn Samsung Medical Center, Sungkyunkwan University School of Medicine |
12:45-13:00 | Lesson from Alveolar Regeneration Program in early lung tumor development and niche remodelling |
Jinwook Choi Gwangju Institute of Science and Technology |
13:00-13:15 | Organoid Modelling of Human Lung Development and Cell Fate Alteration in Human Congenital Pulmonary Diseases |
Kyungtae Lim Korea University |
13:15-13:30 | Discussion | |
Session IV. Recent Advances and Future Perspectives II | ||
Chair : Oh Young Bang (Samsung Medical Center, Sungkyunkwan University School of Medicine) Tae-Young Roh (Ewha Womans University / President of Korean Society for Extracellular Vesicles (KSEV)) |
||
13:30-13:45 | From Organoid Genetics to Mosaic Genetics |
Bon-Kyoung Koo Center for Genome Engineering, Institute for Basic Science |
13:45-14:00 | Pluripotent Stem Cell-Derived Epidermal Organoids: A Novel Model for Skin Research and Extracellular Vesicle-Based Regeneration |
Jungwoon Lee Korea Research Institute of Bioscience and Biotechnology (KRIBB), University of Science & Technology (UST) |
14:00-14:15 | Oral drug delivery via milk-derived extracellular vesicles |
Yoosoo Yang Sungkyunkwan University |
14:15-14:30 | Discussion | |
14:30-14:40 | Break | |
Session V. Advanced disease modeling using Gene-modified cell therapy | ||
Chair : Byung-Ok Choi (Samsung Medical Center, Sungkyunkwan University School of Medicine) Jeehun Lee (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
14:40-14:55 | Engineering retroviral vectors to reduce their oncogenic potentials in gene therapy |
Kwang-il Lim Sookmyung Women’s University |
14:55-15:10 | Advancing cell and gene therapy through microfluidics |
Aram Chung Korea University |
15:10-15:25 | AAV engineering and AAV-mediated gene editing for neurological disorders |
Jae young Lee Ajou University, School of Medicine |
15:25-15:40 | Discussion | |
Session VI. Recent Advances and Future Perspectives III | ||
Chair : SeungKwon You (Korea University) Keon Hee Yoo (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
15:40-15:55 | The potential therapeutic effect of mesenchymal stem cell-derived exosomal microRNAs in bronchopulmonary dysplasia |
Hyeon Ho Kim Samsung Advanced Institute for Health Sciences and Technology(SAIHST), Sungkyunkwan University |
15:55-16:10 | The Path to Clinical Translation: MSC and AAV-Based Approaches for Neuromuscular Disorders |
Jong Wook Chang Samsung Advanced Institute for Health Sciences and Technology(SAIHST), Sungkyunkwan University |
16:10-16:20 | Discussion | |
Session VII. Special Lecture on Policy Act | ||
Chair : Inho Jo (Korean Fund for Regenerative Medicine) Yun Sil Chang (Director of CGTI, SMC, Director of SAIHST, Sungkyunkwan University) |
||
16:20-16:40 | Effects of the ARM Act Revision on the Hospital R&D |
So Ra Park Regenerative Medicine Acceleration Foundation (RMAF) |
16:40-17:00 | The Current State and Goals of Regenerative Medicine Policy in Korea |
Sun-Gill Jung Division of regenerative medicine policy in the Ministry of Health and Welfare |
17:00-17:20 | Application for Advanced Regenerative Medicine Treatment Protocol Review and Guidance on How to Prepare a Treatment Protocol |
Suwon Kim Secretariat for Advanced Regenerative Medicine and Advanced Biological Products Review Committee, Ministry of Health and Welfare |
17:20-17:35 | Discussion | |
17:35- | Adjourn |